Preliminary Program

Preliminary Program
 Thursday, 22 February, 2018 
18:00-19:00Welcome Reception Foyer  
  Friday, 23 February, 2018 
   07:30    Registration 
09:00-11:10Plenary Session 1: Opening Session
Chairs: Stevo Julius, USA, Reuven Zimlichman, Israel
 Hall A
   09:00      Greetings 
09:10Sympathetic Overdrive and the Metabolic Syndrome in Prehypertension Pathophysiology of Obesity and Insulin Resistance in Prehypertension
Stevo Julius, Division of Cardiovascular Medicine, Internal Medicine and Physiology, University of Michigan, Ann Arbor, MI, USA
    09:40    Prehypertension: Past, Present, Future
Reuven Zimlichman, Sackler Faculty of Medicine, Tel Aviv University, The E. Wolfson Medical Center, Holon, Israel
10:10Metabolic Syndrome and Microcirculation
Enrico Agabiti-Rosei, Dept of Clinical and Experimental Sciences, University of Brescia, Italy
    10:40   When should Individuals with High-Normal and Normal Blood Pressure Receive Blood Pressure-Lowering Treatment?  
Alberto Zanchetti, Italy    
11:10-11:40Coffee Break and Posters Viewing Foyer   
11:40-13:40 Plenary Session 2: Prehypertnsion - Challenge and Approach
Chairs: Damiano Rizzoni, Italy, Alberto Zanchetti, Italy
 Hall A
   11:40    Immune System and Microvascular Alterations in Obesity and Hypertension 
Damiano Rizzoni, Dept. of Medical and Surgical Sciences, University of Brescia, Italy
    12:10    The Renin-Angiotensin-Aldosterone System in Prehypertension: Pathology and Intervention
Thomas Unger, CARIM - School for Cardiovascular Diseases, Maastricht University, The Netherlands
    12:40    Markers of Fibrosis - Aging and the Cardovascular System, Blood Pressure – and Statin Therapy.
Daniel A. Duprez, Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA
    13:10    How to Optimize Cardiovascular Risk Management in Hypertension. Evidence from Recent Meta- Analyse 
Gianfranco Parati, Cardiology Unit, S. Luca Hospital, Istituto Auxologico Italiano, Milan and Dept. of Medicine and Surgery, University of Milano-Bicocca, Italy
13:40-14:30Lunch Break and Posters Viewing  
14:30-16:10Plenary Session 3: Prehypertension - Estimation of Risk and Mechanisms
Chairs: Daniel A Duprez, USA, Athanasios J. Manolis,Greece
 Hall A
 14:30How far blood pressure should be lowered in high risk hypertensive patients  
Athanasios J. Manolis, Director, Department of Cardiology "Asklepeion" General Hospital, Athens, Greece 

Device Therapy for the Treatment of Resistant Hypertension
John R. Cockroft, Wales Heart Research Institute, University Hospital Cardiff, UK                                                         

  15:10The Morphology and Pathophysiology of the Capillaries in the Prehypertension State
Sekib Sokolovic, Bosnia and Herzegovina
15:30-16:20 Selected Research (Abstracts)  Hall A
15:30Testosterone Therapy (Tth) Prevents Progression from Prediabetes to Type 2 Diabetes (T2dm) in Hypogonadal: 9-Year Data from a Registry Study
Farid Saad, Medical Affairs Andrology, Bayer AG, Germany
15:40Masked Central Hypertension and White Coat Central Hypertension and Their Association with Target Organ Damage
Chan Joo Lee, Department of Health Promotion, Severance Hospital, South Korea
15:50Association between Arterial Stiffness and Cardiovascular Risk Factors in A Pediatric Population
Maria Perticone, Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Italy
16:00Is Respiratory Modulation of Blood Pressure Enhanced in Pre-Hypertensive Humans?
Andrew Allen, The University of Melbourne, Australia
16:10Age and Gender Influence the Haemodynamic Response to the Active Orthostatic Test
Nina Belova, Medical University of Sofia, Bulgaria
16:20-16:40Coffee Break and Posters Viewing Foyer  
16:40-18:10Plenary Session 4: Prehypertension- Mechanistic Approach
Chairs: Pavel Hamet, Canada, Paolo Palatini, Italy
 Hall A
   16:40 Hemodynamics of Prehypertension
Peter W. de Leeuw, Dept of Medicine University Hospital Maastricht, The Netherlands
   17:00 Arterial Distensibility, Physical Activity and the Metabolic Syndrome
Paolo Palatini, Dept. of Medicine, Vascular Medicine, University of Padova, Italy 
   17:20 Short Sleep Time – a Modifiable Risk Factor for Prehypertension and Hypertension?
Aleksander Prejbisz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
   17:40 New Strategies to Preserve Renal Function in Kidney Disease
Bruno Watschinger, Dept. of Medicine, University of Vienna Medical School, Vienna, Austria
 Saturday, 24 February, 2018 
   07:30 Registration Foyer  
 08:30-09:50Plenary Session 5: Prehypertension, Guidelines and Risk-factors  
Chairs: Giuseppe Mancia, Italy, Andrzej Januszewicz, Poland
 Hall A
   08:30 High Normal Blood Pressure and New Hypertension
Giuseppe Mancia, Emeritus Professor of Medicine, University of Milano-Bicocca, Milan, Italy
   08:50Is Prehypertension a Risk Factor for Cardiovascular Disease? 
Andrzej Januszewicz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland

Arterial Biomarkers in Prehypertension
Charalambos Vlachopoulos, 1st Department of Cardiology, University of Athens Medical School, Greece                  

   09:30Evidence for Increased Risk of Induced Atherosclerosis, Including Subclinical Forms in Autoimmune Disease: The Key to the Success is Multidisciplinary Approach
Ljudmila Stojanovich, Scientific Research Dept. Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia 
09:50-10:20Coffee Break and Posters Viewing Foyer  
10:20-12:20Plenary Session 6: Prehypertension, Development and Contribution of Studies
Chairs: John R. Cockroft, UK, Guido Grassi, Italy
 Hall A
   10:20 Prehypertension in the PAMELA Study: Results and Perspectives
Guido Grassi, Dept of Internal Medicine, University of Milano Biocca, Milan, Italy
   10:40 Polygenic Risk Score as a New Tool for Early Decisions in Cardio-Metabolic Syndrome
Pavel Hamet, University of Montreal and Dept. of Experimental Medicine at McGill University, Canada
   11:00Prehypertension: an Advanced Stage of Abnormal Blood Pressure Increasing with Age
Flávio D. Fuchs, Hospital de Clinicas de Porto Alegre, Brazil   
   11:20 What we Learnt with the PREVER-PREVENTION Trial? 
Sandra Fuchs, Hospital de Clinicas de Porto Alegre, Brazil 
   11:40 Diurnal and Pulsatile Hemodynamics in Prehypertension
Thomas Weber, Dept. of Cardiology, Klinikum Wels-Grieskirchen, Wels, Austria
   12:00 What can we Learn from the Observational Studies and Clinical Trials of Prehypertension?
Yuqing Zhang, Division of Hypertension, Fu Wai Hospita, Beijing, China
 12:20-13:20 Lunch Break and Posters Viewing 
 13:20-14:40Plenary Session 7: Prehypertension and Diabetes
Chairs: Salvatore Novo, Italy, Guntram Schernthaner, Austria 
 Hall A
   13:20Clinical Relevance of Blood Pressure Lowering Effect of Modern Antidiabetic Drugs
Guntram Schernthaner, Dept. of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
   13:40 Masked Hypertension in Diabetes Mellitus
Michael Bursztyn, Department of Medicine, Hypertension Unit Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel
   14:00 Influence of Insulin Resistance and Hyperinsulinism on Heart Rate Variability, Myocardial Strain and Arterial Stiffness
Salvatore Novo, Dept. of Internal Medicine and Cardiovascular Disease, University of Palermo, Italy
   14:20 Treating Hypertension in Patients with Type 2 Diabetes
Brian Rayner, Division of Nephrology & Hypertension, University of Cape Town, South Africa
14:40-15:30 Selected Research (Abstracts) Hall A
14:40Clinical and Genetic Investigations of Alanine-Transaminase Levels as a Marker of NAFLD and NASH in Patients with T2D
Johanne Tremblay, University of Montreal, Canada
14:50Segmental Adrenal Venous Sampling can Clarify the Localization for Hyperaldosteronism in Case with Varying Diagnoses by Central Veins in Presence or Absence of cosyntropin stimulation
Fumitoshi Satoh, Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate
School of Medicine, Japan
15:00Prevalence and Predictors of Pre-hypertension in Bangladesh: Results from the Noncommunicable Diseases Risk Factors Survey
Mujibur Rahman, Dhaka Medical College, Bangladesh
15:10The Influence of Metabolic Factors on Central Blood Pressure Lowering Effect of Different Combinations of Antyhypertensive Drugs
Olena Torbas, NSC Institute of Cardiology n.a. Acad. M.D. Strazhesko, Ukraine
15:20Hypertension and Cardiometabolic Syndrome in Real Life Setting in a Sample of Northern Italy Population
Giuseppina Patrizia Dognini, ASST Bergamo Ovest, Treviglio-Romano Hospital, Italy
 15:30-16:50Plenary Session 8: Prehypertension and Age Groups
Chairs: Cetin Erol, Turkey, Ian B. Wilkinson, UK
 Hall A
   15:30 Markers of Early Cardiovascular Dysfunction in Prehypertension - Difference Between Youth and Elderly
Bojan Jelakovic, University of Zagreb School of Medicine, University Hospital Center Zagreb, Croatia   
   15:50 Prehypertension in Children and Adolescents – an Overwiew
Mieczysław Litwin, Dept. of Nephrology and Arterial Hypertension, The Children’s Memorial Health Institute, Warsaw, Poland
   16:10 Why Treat Young People with Borderline Hypertension?
Ian B. Wilkinson, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Cambridge, UK 
   16:30 Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
Cetin Erol, Ankara University, Faculty of Medicine, bn-i Sina Hospital, Dept. of Cardiology, Ankara, Turkey
 16:50-17:10 Coffee Break and Posters Viewing Foyer  
 17:10-18:50Plenary Session 9: Prehypertension and the Heart
Chairs: Bojan Jelakovic, Croatia, Ian B. Wilkinson, UK
 Hall A
   17:10 Predictive Value of CAC Progression for Coronary and CV Events in Prehypertension Most Recent CT Scan Overrides CAC Progression in Coronary and CV
Raimund Erbel, Dept.of Cardiology, West German Heart Centre Essen, Division of Internal Medicine, University Essen, Germany
   17:30 The Hypertensive Patient with Angina: Tips and Tricks in Management
Giuseppe Ambrosio, Dept. of Cardiology, University of Perugia School of Medicine, Perugia, Italy
   17:50 Threshold Level of Exercise Systolic Blood Pressure at Moderate Workload in Predicting Coronary Heart Disease in Healthy Middle-aged Men
Sverre E. Kjeldsen, Dept. of Cardiology, University of Oslo Ullevaal Hospital, Norway
   18:10 Clinical Importance of Exercise Capacity as a Determinant of Cardiovascular Health
Arno Schmidt-Trucksaess, Division Sports and Exercise Medicine, Medical Faculty, University Basel, Switzerland
   18:30 How to Undertake the Sub Typing of Primary Aldosteronism?
CT- strategy?
AVS strategy?
Functional imaging?
Gian Paolo Rossi, Dept. of Medicine, University of Padova, Italy
 20:00-22:30Gala Dinner (Optional) Hall A
 Sunday, 25 February, 2018 
   07:30 Registration Foyer  
 08:30-10:30 Plenary Session 10: Management of Prehypertension and Hypertension in Women of Childbearing Age
Chairs: Renata Cifkova, Czech Republic, Danuta Czarnecka, Poland
 Hall A
   08:30 Prehypertension and Hypertension in Pregnancy
Renata Cifkova, Czech Republic
   09:00 Hypertensive Disorders of Pregnancy – Do they Influence Future Cardiovascular Health of Mother or Children?
Katarzyna Stolarz-Skrzypek, Poland
   09:30 Diagnostic Workup and Treatment Strategies for Prehypertension in Women of Childbearing Potential
Agnieszka Olszanecka, Poland
   10:00 Should Hypertensive Disorders of Pregnancy be Considered as a Prehypertension State 
Jack Blacher
   10:30 Haemodyanics of Pregnancy Associated Hypertension
John R. Cockroft, Wales Heart Research Institute, University Hospital Cardiff, UK
11:00-12:00Panel Discussion – The New ACC/AHA Guidelines and Hypertension
Daniel A. Duprez, USA, Stevo Julius, USA,
Sverre, E. Kjeldsen, Norway, Giuseppe Mancia, Italy, 
Reuvan Zimlichman, Israel
    12:00-12:30 Coffee Break and Posters Viewing  Foyer  
12:30-13:30Closing Session 11: Summary
Chairs: Stevo Julius, USA, Giuseppe Mancia, Italy 
Reuven Zimlichman, Israel
 Hall A
12:30 The Potential Importance of Antihypertensive Properties of Non-antihypertensive Drugs in Patients with Prehypertension
Marcin Adamczak, Dept. of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Poland
12:50 Patient Oriented Prevention of Cardiovascular Complications : New Targets ,New Diagnostic Tools, New Treatments (Hyperlipidemia , Inflammation, Hypertension and More..) 
Dov Gavish, Medicine A Wolfson Hospital, Sackler Faculty of Medicine Tel Aviv University, Israel
13:10 Artificial Intelligence and Hypertension: New Approach in Understanding of Possible Mechanisms
Branislav Milovanovic, Serbia
Stevo Julius, USA, Giuseppe Mancia, Italy
Reuven Zimlichman, Israel
 Hall A